Stereotaxis Inc (STXS): Next-Year EPS Estimate 32.47%
As of 2026-06-04, Stereotaxis Inc (STXS) has a next-year EPS growth estimate of 32.47%.
On 2026-05-13, analyst consensus for STXS's next-year EPS growth shifted from 40.28% to 32.47% — a negative change of 7.81 percentage points. The revised estimate has been sustained across 17 subsequent trading sessions. Current-year growth is projected at 23.00%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- EPS growth next year
- 32.47%
- EPS growth this year
- 23.00%
- EPS next quarter (est)
- -$0.05
- Last price
- $1.88
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 32.47% | 23.00% | -$0.05 | $1.88 |
| 2026-06-03 | 32.47% | 23.00% | -$0.05 | $1.84 |
| 2026-06-02 | 32.47% | 23.00% | -$0.05 | $1.97 |
| 2026-06-01 | 32.47% | 23.00% | -$0.05 | $1.94 |
| 2026-05-31 | 32.47% | 23.00% | -$0.05 | $1.98 |
| 2026-05-28 | 32.47% | 23.00% | -$0.05 | $2.08 |
| 2026-05-27 | 32.47% | 23.00% | -$0.05 | $2.01 |
| 2026-05-26 | 32.47% | 23.00% | -$0.05 | $1.95 |
| 2026-05-25 | 32.47% | 23.00% | -$0.05 | $1.92 |
| 2026-05-24 | 32.47% | 23.00% | -$0.05 | $1.92 |
| 2026-05-21 | 32.47% | 23.00% | -$0.05 | $1.90 |
| 2026-05-20 | 32.47% | 23.00% | -$0.05 | $1.85 |
| 2026-05-19 | 32.47% | 23.00% | -$0.05 | $1.73 |
| 2026-05-18 | 32.47% | 23.00% | -$0.05 | $1.78 |
| 2026-05-17 | 32.47% | 23.00% | -$0.05 | $1.85 |
| 2026-05-14 | 32.47% | 23.00% | -$0.05 | $1.94 |
| 2026-05-13 | 32.47% | 23.00% | -$0.05 | $1.87 |
| 2026-05-12 | 40.28% | 28.00% | -$0.05 | $1.92 |
| 2026-05-11 | 40.28% | 28.00% | -$0.05 | $1.88 |
| 2026-05-10 | 40.28% | 28.00% | -$0.05 | $1.90 |
| 2026-05-07 | 33.33% | 25.60% | -$0.05 | $1.90 |
| 2026-05-06 | 33.33% | 25.60% | -$0.05 | $1.92 |
| 2026-05-05 | 33.33% | 25.60% | -$0.05 | $1.92 |
| 2026-05-04 | 33.33% | 25.60% | -$0.05 | $1.90 |
| 2026-05-03 | 33.33% | 25.60% | -$0.05 | $1.93 |
| 2026-04-30 | 33.33% | 25.60% | -$0.05 | $1.87 |
| 2026-04-29 | 33.33% | 25.60% | -$0.05 | $1.82 |
| 2026-04-28 | 33.33% | 25.60% | -$0.05 | $1.86 |
| 2026-04-27 | 33.33% | 25.60% | -$0.05 | $1.93 |
| 2026-04-26 | 33.33% | 25.60% | -$0.05 | $1.93 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Stereotaxis Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Stereotaxis Inc (STXS) has a next-year EPS growth estimate of 32.47%, based on analyst consensus.
When was the latest EPS estimate revision for STXS?▾
The most recent revision occurred on 2026-05-13, when analysts adjusted the next-year EPS growth estimate from 40.28% to 32.47%.
What sector and industry does Stereotaxis Inc belong to?▾
Stereotaxis Inc operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. STXS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Stereotaxis Inc (STXS) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports